相似文献
1
Use of beta-lactamase inhibitors in disk tests to detect plasmid-mediated AmpC beta-lactamases.
J Clin Microbiol. 2004 May;42(5):2203-6. doi: 10.1128/JCM.42.5.2203-2206.2004.
2
[Detection of plasmid-mediated AmpC beta-lactamase in clinical isolates of cefoxitin-resistant Escherichia coli and Klebsiella pneumoniae].
Mikrobiyol Bul. 2012 Jul;46(3):375-85.
3
Practical methods using boronic acid compounds for identification of class C beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
J Clin Microbiol. 2005 Jun;43(6):2551-8. doi: 10.1128/JCM.43.6.2551-2558.2005.
4
Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
J Clin Pathol. 2008 May;61(5):642-4. doi: 10.1136/jcp.2007.053470. Epub 2007 Dec 5.
5
[Identification of a plasmid-mediated AmpC beta-lactamase from clinical isolates of Escherichia coli and Klebsiella pneumoniae].
Zhonghua Jie He He Hu Xi Za Zhi. 2005 Oct;28(10):685-8.
6
Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases.
J Clin Microbiol. 1994 Mar;32(3):691-6. doi: 10.1128/jcm.32.3.691-696.1994.
7
Detection of plasmid-mediated AmpC β-lactamase in Escherichia coli and Klebsiella pneumoniae.
Indian J Med Microbiol. 2013 Jan-Mar;31(1):53-9. doi: 10.4103/0255-0857.108723.
8
Evaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis.
Antimicrob Agents Chemother. 2009 Jan;53(1):146-9. doi: 10.1128/AAC.00862-08. Epub 2008 Oct 27.
9
Prevalence and resistance patterns of extended-spectrum and AmpC β-lactamase in Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Salmonella serovar Stanley in a Korean tertiary hospital.
APMIS. 2010 Oct;118(10):801-8. doi: 10.1111/j.1600-0463.2010.02663.x. Epub 2010 Aug 17.
10
A simple phenotypic method for differentiation between acquired and chromosomal AmpC beta-lactamases in Escherichia coli.
Enferm Infecc Microbiol Clin. 2006 Jun-Jul;24(6):370-2. doi: 10.1157/13089690.
引用本文的文献
1
Systematic Review of Plasmid AmpC Type Resistances in and and Preliminary Proposal of a Simplified Screening Method for .
Microorganisms. 2022 Mar 14;10(3):611. doi: 10.3390/microorganisms10030611.
2
Detection of ESBL among AmpC producing enterobacteriaceae using inhibitor-based method.
Pan Afr Med J. 2013;14:28. doi: 10.11604/pamj.2013.14.28.1347. Epub 2013 Jan 20.
3
Current concepts in laboratory testing to guide antimicrobial therapy.
Mayo Clin Proc. 2012 Mar;87(3):290-308. doi: 10.1016/j.mayocp.2012.01.007.
4
AmpC beta-lactamases.
Clin Microbiol Rev. 2009 Jan;22(1):161-82, Table of Contents. doi: 10.1128/CMR.00036-08.
5
Prevalence of AmpC and other beta-lactamases in enterobacteria at a large urban university hospital in Brazil.
Diagn Microbiol Infect Dis. 2008 Jan;60(1):79-87. doi: 10.1016/j.diagmicrobio.2007.07.018. Epub 2007 Sep 27.
6
Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, Calgary.
Emerg Infect Dis. 2007 Mar;13(3):443-8. doi: 10.3201/eid1303.060447.
7
Evaluation of beta-lactamase inhibitors in disk tests for detection of plasmid-mediated AmpC beta-lactamases in well-characterized clinical strains of Klebsiella spp.
J Clin Microbiol. 2005 Aug;43(8):4168-71. doi: 10.1128/JCM.43.8.4168-4171.2005.
8
AmpC disk test for detection of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal AmpC beta-lactamases.
J Clin Microbiol. 2005 Jul;43(7):3110-3. doi: 10.1128/JCM.43.7.3110-3113.2005.
9
Practical methods using boronic acid compounds for identification of class C beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
J Clin Microbiol. 2005 Jun;43(6):2551-8. doi: 10.1128/JCM.43.6.2551-2558.2005.
本文引用的文献
1
Association between handling of pet treats and infection with Salmonella enterica serotype newport expressing the AmpC beta-lactamase, CMY-2.
J Clin Microbiol. 2003 Oct;41(10):4578-82. doi: 10.1128/JCM.41.10.4578-4582.2003.
2
AmpC beta-lactamases: what do we need to know for the future?
J Antimicrob Chemother. 2003 Jul;52(1):2-4. doi: 10.1093/jac/dkg284. Epub 2003 May 29.
3
Occurrence of extended-spectrum and AmpC beta-lactamases in bloodstream isolates of Klebsiella pneumoniae: isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC beta-lactamases.
J Clin Microbiol. 2003 Feb;41(2):772-7. doi: 10.1128/JCM.41.2.772-777.2003.
4
Occurrence and detection of AmpC beta-lactamases among Gram-negative clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur Hospital, Delhi, India.
J Antimicrob Chemother. 2003 Feb;51(2):415-8. doi: 10.1093/jac/dkg098.
5
Further modification of the Hodge test to screen AmpC beta-lactamase (CMY-1)-producing strains of Escherichia coli and Klebsiella pneumoniae.
J Microbiol Methods. 2002 Nov;51(3):407-10. doi: 10.1016/s0167-7012(02)00053-2.
6
7
Cephalosporin-derived inhibitors of beta-lactamase. Part 4: The C3 substituent.
Bioorg Med Chem Lett. 2002 Jun 17;12(12):1663-6. doi: 10.1016/s0960-894x(02)00205-6.
8
Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.
J Clin Microbiol. 2002 Jun;40(6):2153-62. doi: 10.1128/JCM.40.6.2153-2162.2002.
9
Plasmid-determined AmpC-type beta-lactamases.
Antimicrob Agents Chemother. 2002 Jan;46(1):1-11. doi: 10.1128/AAC.46.1.1-11.2002.
10
Evidence for transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans.
Antimicrob Agents Chemother. 2001 Oct;45(10):2716-22. doi: 10.1128/AAC.45.10.2716-2722.2001.
Zotero 插件